Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - apomorphini hydrochloridum hemihydricum - soluzione per infusione in siringa preriempita - apomorphini hydrochloridum hemihydricum 50 mg, acidum hydrochloricum q.s. ad ph, e 223 5 mg, aqua ad iniectabilia ad solutionem pro 10 ml corresp., natrium 1.2 mg. - morbo di parkinson - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - atorvastatinum, perindoprilum, amlodipinum - compressa rivestita con film - atorvastatinum 10 mg ut atorvastatinum calcicum trihydricum 10.82 mg, perindoprilum argininum 5 mg corresp. perindoprilum 3.395 mg, amlodipinum 5 mg ut amlodipini besilas 6.935 mg, calcii carbonas, lactosum monohydricum 27.46 mg, cellulosum microcristallinum, carboxymethylamylum natricum corresp. natrium 0.25 - 0.38 mg, hydroxypropylcellulosum, maltodextrinum, magnesii stearas, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, e 172 (flavum), pro compresso obducto. - ipertensione; maladie coronaire stabile - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - atorvastatinum, perindoprilum, amlodipinum - compressa rivestita con film - atorvastatinum 20 mg ut atorvastatinum calcicum trihydricum 21.64 mg, perindoprilum argininum 5 mg corresp. perindoprilum 3.395 mg, amlodipinum 5 mg ut amlodipini besilas 6.935 mg, calcii carbonas, lactosum monohydricum 54.92 mg, cellulosum microcristallinum, carboxymethylamylum natricum corresp. natrium 0.5 - 0.75 mg, hydroxypropylcellulosum, maltodextrinum, magnesii stearas, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, e 172 (flavum), pro compresso obducto. - ipertensione; maladie coronaire stabile - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - atorvastatinum, perindoprilum, amlodipinum - compressa rivestita con film - atorvastatinum 20 mg ut atorvastatinum calcicum trihydricum 21.64 mg, perindoprilum argininum 10 mg corresp. perindoprilum 6.790 mg, amlodipinum 5 mg corresp. amlodipini besilas 6.935 mg, calcii carbonas, lactosum monohydricum 54.92 mg, cellulosum microcristallinum, carboxymethylamylum natricum corresp. natrium 0.5 - 0.75 mg, hydroxypropylcellulosum, maltodextrinum, magnesii stearas, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, e 172 (flavum), pro compresso obducto. - ipertensione; maladie coronaire stabile - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - atorvastatinum, perindoprilum, amlodipinum - compressa rivestita con film - atorvastatinum 20 mg ut atorvastatinum calcicum trihydricum 21.64 mg, perindoprilum argininum 10 mg corresp. perindoprilum 6.790 mg, amlodipinum 10 mg ut amlodipini besilas 13.87 mg, calcii carbonas, lactosum monohydricum 54.92 mg, cellulosum microcristallinum, carboxymethylamylum natricum, natrium 0.5 - 0.75 mg, hydroxypropylcellulosum, maltodextrinum, magnesii stearas, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, e 172 (flavum), pro compresso obducto. - ipertensione; maladie coronaire stabile - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - atorvastatinum, perindoprilum, amlodipinum - compressa rivestita con film - atorvastatinum 40 mg ut atorvastatinum calcicum trihydricum 43.28 mg, perindoprilum argininum 10 mg corresp. perindoprilum 6.790 mg, amlodipinum 10 mg ut amlodipini besilas 13.87 mg, calcii carbonas, lactosum monohydricum 109.84 mg, cellulosum microcristallinum, carboxymethylamylum natricum corresp. natrium 1 - 1.5 mg, hydroxypropylcellulosum, maltodextrinum, magnesii stearas, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, e 172 (flavum), pro compresso obducto. - ipertensione; maladie coronaire stabile - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - drospirenone ed estrogeno - drospirenone ed estrogeno

Unione Europea - italiano - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - malattia polmonare, ostruttiva cronica - farmaci per le malattie respiratorie ostruttive, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Unione Europea - italiano - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - malattia polmonare, ostruttiva cronica - farmaci per le malattie respiratorie ostruttive, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Italia - italiano - myHealthbox

zentiva italia - sumatriptan - compressa rivestita - 50 mg - - analgesici: preparazioni anti-emicrania; agonisti selettivi della serotonina (5-ht1) - trattamento acuto degli attacchi di emicrania con o senza aura